HeraMED Limited (ASX:HMD)
Share Price and News


Company Profile:

HeraMED is an Israeli company founded in 2011. Its flagship product is HeraBEAT, smartphone-based, efficient fetal heartbeat monitoring system for expectant mothers. As on 12th December, the company successfully completed its IPO of $6 million (NIS 15.8 million) at A$0.20 per share and subsequently listed on ASX.



Code : ASX:HMD Healthcare Company